Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney

Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney

Autor Pinheiro, SVB Google Scholar
Silva, ACSE Google Scholar
Sampaio, W. O. Google Scholar
Paula, R. D. de Google Scholar
Mendes, E. P. Google Scholar
Bontempo, E. D. Google Scholar
Pesquero, João Bosco Autor UNIFESP Google Scholar
Walther, T. Google Scholar
Alenina, N. Google Scholar
Bader, Michael Autor UNIFESP Google Scholar
Bleich, M. Google Scholar
Santos, RAS Google Scholar
Instituição Universidade Federal de Minas Gerais (UFMG)
Universidade Federal de São Paulo (UNIFESP)
Erasmus MC
Max Delbruck Ctr Mol Med
Univ Kiel
Resumo It has been described recently that the nonpeptide AVE 0991 (AVE) mimics the effects of angiotensin-(1-7) [Ang-(1-7)] in bovine endothelial cells. in this study, we tested the possibility that AVE is an agonist of the Ang-(1-7) receptor Mas, in vitro and in vivo. in water-loaded C57BL/6 mice, AVE (0.58 nmol/g body weight) produced a significant reduction in urinary volume (0.06 +/- 0.03 mL/60 min [n = 9] versus 0.27 +/- 0.05 [n = 9]; P < 0.01), associated with an increase in urinary osmolality. the Ang-(1-7) antagonist A-779 completely blocked the antidiuretic effect of AVE. As observed previously for Ang-(1-7), the antidiuretic effect of AVE after water load was blunted in Mas-knockout mice (0.37 +/- 0.10 mL/60 min [n = 9] versus 0.27 +/- 0.03 mL/60 min [n = 11] AVE-treated mice). in vitro receptor autoradiography in C57BL/6 mice showed that the specific binding of I-125-Ang-(1-7) to mouse kidney slices was displaced by AVE, whereas no effects were observed in the binding of I-125-angiotensin II or I-125-angiotensin IV. Furthermore, AVE displaced the binding of I-125-Ang-(1-7) in Mas-transfected monkey kidney cells (COS) cells (IC50 = 4.75 x 10(-8) mol/L) and of rhodamine-Ang-(1-7) in Mas-transfected Chinese hamster ovary (CHO) cells. It also produced NO release in Mas-transfected CHO cells blocked by A-779 but not by angiotensin II type-1 (AT1) and AT2 antagonists. Contrasting with these data, the antidiuretic effect of AVE was totally blocked by AT2 antagonists and partially blocked (approximate to 60%) by AT1 antagonists. the binding data, the results obtained in Mas-knockout mice and in Mas-transfected cells, show that AVE is a Mas receptor agonist. Our data also suggest the involvement of AT(2)/AT(1)-related mechanisms, including functional antagonism, oligomerization or cross-talk, in the renal responses to AVE.
Palavra-chave receptors, angiotensin
angiotensin
angiotensin II
Idioma Inglês
Data de publicação 2004-10-01
Publicado em Hypertension. Philadelphia: Lippincott Williams & Wilkins, v. 44, n. 4, p. 490-496, 2004.
ISSN 0194-911X (Sherpa/Romeo, fator de impacto)
Publicador Lippincott Williams & Wilkins
Extensão 490-496
Fonte http://dx.doi.org/10.1161/01.HYP.0000141438.64887.42
Direito de acesso Acesso aberto Open Access
Tipo Artigo
Web of Science WOS:000224056000024
Endereço permanente http://repositorio.unifesp.br/handle/11600/27953

Exibir registro completo




Arquivo

Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta